BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6252570)

  • 21. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 22. The biology of hepadnaviruses.
    Howard CR
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1215-35. PubMed ID: 3014045
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B virus markers in patients with schistosomiasis, liver cirrhosis and hepatocellular carcinoma in Khartoum, Sudan.
    Itoshima T; Fedail SS; Suliman I; Ali AK; Higashi T; Tsuji T
    Acta Med Okayama; 1989 Aug; 43(4):241-4. PubMed ID: 2552752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic markers of hepatitis A and B in acute and chronic liver disease.
    Czaja AJ
    Mayo Clin Proc; 1979 Nov; 54(11):721-32. PubMed ID: 226813
    [No Abstract]   [Full Text] [Related]  

  • 26. Serologic evaluation of viral hepatitis.
    Hollinger FB
    Hosp Pract (Off Ed); 1987 Feb; 22(2):101-14. PubMed ID: 3100558
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis B vaccine.
    Lancet; 1980 Dec; 2(8206):1229-30. PubMed ID: 6108398
    [No Abstract]   [Full Text] [Related]  

  • 28. The relation between hepatitis B virus infection and hepatocellular carcinoma.
    Popper H
    Hepatogastroenterology; 1986 Feb; 33(1):2-5. PubMed ID: 3007316
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.
    Beasley RP; Hwang LY; Lin CC; Chien CS
    Lancet; 1981 Nov; 2(8256):1129-33. PubMed ID: 6118576
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis B virus markers in the internist's practice].
    Ivashkin VT; Khazanov AI; Ivlev AS; Vasil'eva AP; Rumiantsev ON; Krivoruchko VA; Lytsar' BN; Izgorodin AS
    Klin Med (Mosk); 1991 Sep; 69(9):51-4. PubMed ID: 1803151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis B virus. Immuno-epidemiological survey in different samples of the Venezuelan population].
    Machado I; de Márquez M; Bianco N
    G E N; 1983; 37(3):233-40. PubMed ID: 6442900
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis B virus precore and core gene mutations in chronic hepatitis B and hepatocellular carcinoma patients.
    Wen YM
    J Intern Med; 1993 Nov; 234(5):441-5. PubMed ID: 8228787
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistent infection of humans with hepatitis B virus: mechanisms and consequences.
    Ganem D
    Rev Infect Dis; 1982; 4(5):1026-47. PubMed ID: 6293033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carrier state of hepatitis B virus. II. Various immunological aspects].
    Cianciara J
    Pol Arch Med Wewn; 1980 Jan; 63(1):21-31. PubMed ID: 6965785
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of markers of the hepatitis B virus in households of HBs antigen carriers].
    Saraux JL; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1985 May; 9(5):403-8. PubMed ID: 3891493
    [No Abstract]   [Full Text] [Related]  

  • 37. [Markers of hepatitis B virus in chronic liver diseases].
    Maleev A; Ognianov M; Ninova D
    Ter Arkh; 1987; 59(7):13-7. PubMed ID: 3672351
    [No Abstract]   [Full Text] [Related]  

  • 38. [The history of hepatitis B virus].
    Scheutz F
    Tandlaegebladet; 1981 Sep; 85(15):459-60. PubMed ID: 6272441
    [No Abstract]   [Full Text] [Related]  

  • 39. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

  • 40. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
    Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
    Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.